Read More Pharma Industry News Can Innovent’s PECONDLE rewrite China’s psoriasis treatment playbook with its IL-23p19 antibody? Innovent Biologics wins NMPA nod for PECONDLE, China’s first IL-23p19 psoriasis biologic. Learn how this reshapes autoimmune therapy options for millions. byVenkateshNovember 28, 2025